These observations may suggest a protective role of α7nAChR signaling in ILC2s against ILC2-mediated allergic inflammation and the possibility that α7nAChR could be a potential therapeutic target for the treatment of ILC2-mediated asthma. The gene discussed is CHRNA7; the disease is asthma.